Table 1.

Summary data of patients who received PVP combined with radiotherapy

Case No.	Sex	Age(years)	Primary tumor	Pathology	Tumor stagea	Level for PVPb	Level for RTc	Follow-up period	outcome
1	Fd	38	Breast	Invasive lobular carcinoma	T2N2M1	T12	T12	19	Dead
2	F	45	Breast	adenocarcinoma	T1N1M1	T11	T11	10	Lost follow-up
3	F	60	Breast	Medullary carcinoma	T1N3M1	L2	L2	24	Alive
4	Me	72	Prostate	Adenocarcinoma	T2N1M1	T10	T10	13	Dead
5	M	76	Prostate	Adenocarcinoma	T2N0M1	T12	T12	15	Alive
6	F	59	Lung	NSCLCf	T2aN0M1b	L4	L4	24	Alive
7	M	54	Lung	SCLCg	T1cN1M1b	L3	L1-5	24	Dead
8	M	75	Hepatocellular	Clear cell carcinoma	T2N1M1	T12,L1	T11-L1	12	Alive
9	F	57	Thyroid	Undifferentiated carcinoma	T4aN1aM1	L1-3	T12-L4	7	Dead

^aTumor stage = when patients was admitted to our department

^bPVP = percutaneous vertebroplasty

^cRT = radiotherapy

^dF = Female

^eM = Male

^fNSCLC = non-small-cell lung cancer

^gSCLC = small-cell lung cancer